CRGC News Broadcast NB-2021-013
August 6, 2021
SEER SINQ Updates
to a listing of SEER SINQ's that have been finalized during the months of May thru July 2021.
Highlights of this listing include:
informs whether Thyroid Imaging Reporting and Data System (TI-RADS) 4a, 4b, or 5 on imaging is diagnostic of thyroid cancer and if so, can it be used for date of diagnosis?
advises how to correctly code 2021 neoadjuvant therapy fields when neoadjuvant therapy and surgery were part of first course of treatment plans but was never completed.
instructs if Serum Protein Electrophoresis (SPEP) can be used as a definitive diagnostic method in the absence of a bone marrow biopsy for Plasma Cell Myeloma cases.
If you have questions or concerns regarding any of the content of this CRGC News Broadcast please
Mignon Dryden, CTR
Cancer Registry of Greater California